← All trials
NCT04855877
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 6, 2021
- Primary completion
- Jun 1, 2023
- Completion date
- Jul 1, 2023
- First posted
- Apr 22, 2021
- Last posted
- Jul 28, 2021
- Enrollment
- 104
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of LiegeLead sponsor
- University of LiegeReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.